USA – Biomea Fusion, a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers, announced the appointment of Franco…
Read MoreFranco Valle appointed chief financial officer at Biomea fusion in move to strengthen company’s executive team
